Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif

Clinical trial NCT00317941 · COMPLETED

Trial details

NCT number: NCT00317941
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2006-03-01
Primary completion: 2008-04-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.